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Introduction
The gene for the BAT1 protein was first discovered in the human
major histocompatibility complex (Spies et al., 1989a; Spies et al.,
1989b). BAT1 might be a negative regulator of inflammation, acting
by downregulating the production of cytokines, including TNFα,
IL1 and IL6 (Allcock et al., 2001). The human BAT1 protein has
been identified as an ATP-dependent RNA helicase (Peelman et al.,
1995) of the DExD/H family and is homologous to the previously
described p47 protein of rat (Nair et al., 1992). Rediscovered as an
essential RNA splicing factor, and sometimes renamed UAP56 in
mammals (Fleckner et al., 1997), Sub2p in yeast (Libri et al., 2001;
Zhang and Green, 2001) and HEL in Drosophila (Gatfield et al.,
2001), this helicase enables U2 small nuclear ribonucleoprotein
(snRNP) attachment to the splicing branch point (Fleckner et al.,
1997). In cells, UAP56 is recruited to sites with nascent transcripts
in a splicing-dependent manner (Custodio et al., 2004). RNA
splicing in both metazoans and yeast requires several helicases of
the DExD/H family (reviewed in Staley and Guthrie, 1998; Tanner
and Linder, 2001).
RNA splicing is coupled to RNA export from the nucleus; the
mRNA produced from intron-containing precursors is exported more
efficiently than are identical mRNAs produced without splicing (Luo
and Reed, 1999). In one model, this coupling is achieved by the
splicing-dependent formation of an exon junction complex (EJC)
located at sites 20-24 bases upstream from exon-exon junctions and
containing UAP56, the RNA splicing factor SRm160 (SRRM1),
RNPS1, Y14, DEK, Aly/REF (Kataoka et al., 2000; Le Hir et al.,
2000a; Le Hir et al., 2000b), Magoh (Kataoka et al., 2001), eIF4A3
(Chan et al., 2004), Acinus and SAP18 (Tange et al., 2005). The
crystal structure of a core complex with eIF4A3, MLN51, MAGOH
and Y14 bound to polyU has been solved (Andersen et al., 2006).
In vitro, at least two proteins of the complex, Y14 and Magoh, may
bind to the NXF1 (TAP)-p15 heterodimer (Kataoka et al., 2001).
Orthologs of NXF1 are essential for the nuclear export of mRNA
(Herold et al., 2001; Longman et al., 2003). NXF1 might, in turn,
bind directly at nuclear pores (Forler et al., 2004), or bind transportin
2 (karyopherin beta 2b) (Shamsher et al., 2002) for export of the
complex from the nucleus.
Some recent data suggests an alternative model in which UAP56
and Aly/REF are associated with a spliced mRNA not at the EJC,
but rather as part of the TREX complex, which is recruited to the
5 end of the mRNA (Cheng et al., 2006). In this model, it is the
bound TREX complex that is required for efficient mRNA export
and which might interact with NXF1. In addition to UAP56 and
Aly/REF, the TREX complex also contains Tex1 and the THO
proteins (Jimeno et al., 2002; Reed and Cheng, 2005; Masuda et
al., 2005).
At least four RNA helicases with ATPase activity might play
roles in mRNA delivery to the cytoplasm. UAP56 orthologs are
essential mRNA-export factors in yeast, Drosophila, Xenopus and
Caenorhabditis elegans (Gatfield et al., 2001; Jensen et al., 2001;
Luo et al., 2001; MacMorris et al., 2003; Strasser and Hurt, 2001),
whereas, in human cells, UAP56, or the related protein URH49,
are essential for bulk mRNA export (Kapadia et al., 2006). UAP56,
and a second putative helicase, Dbp5, bind co-transcriptionally to
the Balbiani ring pre-mRNA and remain with the mRNP particle
all the way to the nuclear pore (Kiesler et al., 2002; Zhao et al.,
2002). Dbp5 might be involved in the release of mRNP at the
cytoplasmic face of the nuclear pore (Hodge et al., 1999; Snay-
Hodge et al., 1998; Strahm et al., 1999; Tseng et al., 1998). The
core of the EJC, which is proposed to be essential for efficient
mRNA export, consists of eIF4A3, Y14, Magoh and MLN51 (Ballut
et al., 2005). The helicase eIF4E supports the nuclear export of a
family of proliferation-related mRNAs sharing a 50-nucleotide
The major-histocompatibility-complex protein UAP56 (BAT1)
is a DEAD-box helicase that is deposited on mRNA during
splicing. UAP56 is retained on spliced mRNA in an exon
junction complex (EJC) or, alternatively, with the TREX
complex at the 5 end, where it might facilitate the export of
the spliced mRNA to the cytoplasm. Using confocal microscopy,
UAP56 was found to be concentrated in RNA-splicing speckled
domains of nuclei but was also enriched in adjacent nuclear
regions, sites at which most mRNA transcription and splicing
occur. At speckled domains, UAP56 was in complexes with the
RNA-splicing and -export protein SRm160, and, as measured
by FRAP, was in a dynamic binding equilibrium. The
application of an in vitro FRAP assay, in which fluorescent
nuclear proteins are photobleached in digitonin-extracted cells,
revealed that the equilibrium binding of UAP56 in complexes
at speckled domains was directly regulated by ATP binding.
This was confirmed using a point mutant of UAP56 that did
not bind ATP. Point mutation of UAP56 to eliminate ATP
binding did not affect RNA splicing, but strongly inhibited the
export of mRNA to the cytoplasm.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/121/9/1526/DC1
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sequence element in their 3 untranslated region (Culjkovic et al.,
2006).
The role of ATP binding, hydrolysis and exchange in the RNA-
export functions of these RNA helicases has not been determined.
The crystal structure of UAP56 with bound nucleotide has been
solved (Shi et al., 2004; Zhao et al., 2004).
We have previously used fluorescence recovery after
photobleaching (FRAP) to show an ATP-dependent mobility of the
EJC proteins SRm160 and RNPS1 at RNA-splicing speckled
domains (Wagner et al., 2004). This was achieved with the use of
an in vitro FRAP assay in which fluorescent fusion proteins are
photobleached in diginonin-permeabilized cells. Nuclear envelopes
remain intact in this assay and molecules small enough to diffuse
through nuclear pores, such as ATP, can be added or removed. This
assay revealed that SRm160 and RNPS1 are bound at speckled
domains, and that ATP, but not its hydrolysis, is required for their
release from those binding sites. Because neither protein shows
evidence of binding ATP, we hypothesized that they could be
released from a complex by an ATP-dependent factor, such as a
DEAD-box helicase, that might induce a conformational change
without ATP hydrolysis. UAP56 resides in both splicing and RNA-
export complexes with SRm160 and RNPS1, making UAP56 a good
candidate for mediating their ATP-dependent speckled-domain
binding. In addition, the mRNA-binding protein poly(A) binding
protein 2 and the mRNA-export factor NXF1 have a FRAP recovery
at speckled domains that is slowed by ATP reduction in cells
(Calapez et al., 2002). UAP56 is a good candidate for mediating
multiple ATP effects on the assembly and functioning of mRNA-
export complexes.
In this study, we characterized the cell biology of UAP56,
determined its distribution in the nucleus and tracked its
redistribution in mitotic cells. Using the technique of FRAP, we
characterized the kinetics of UAP56 binding to structures at RNA-
splicing speckled domains of the nucleus. In vitro FRAP revealed
that the assembly of UAP56 into complexes at RNA-splicing
speckled domains required ATP. Using fluorescence resonance
energy transfer (FRET), we were able to show that UAP56 and
SRm160 inhabit the same complexes at RNA-splicing speckled
domains. Mutants of UAP56 with greatly reduced ATP-binding
affinity did not affect the ATP-dependent binding of SRm160 at
speckled domains. They did, however, inhibit RNA export by a
dominant-negative mechanism, showing the central role of ATP
binding to UAP56 in mRNA-export-complex assembly.
Results 
In order to localize endogenous UAP56 in the nucleus, we generated
a rabbit peptide antibody against the GAEPAKKDVKGSYVC
internal sequence of UAP56. On a western blot of HeLa and Caski
cell lysates, the antiserum detected a single band for each cell line
with an approximate molecular mass of 56 kDa, as shown in Fig.
1A. The more-recently discovered URH49 (UAP56 related helicase,
49 kDa) is an RNA helicase that, in humans, has a 90% similarity
to UAP56 (Pryor et al., 2004). It contains a sequence that is 62.5%
identical (STPAPPKKDIKGSYVS) to our peptide antigen. In order
to test whether the polyclonal anti-UAP56 antibody was recognizing
this peptide sequence in URH49, either GST-URH49 or GST-
UAP56 was expressed in bacteria and affinity purified on
Glutathione-Sepharose. Western blotting with the polyclonal
antiserum against UAP56 showed that the antibody had a strong
preference for UAP56, but at high antibody concentrations there
was some crossreactivity with URH49 (Fig. 1B).
To eliminate any possible crossreactions, UAP56-specific
antibodies were isolated by affinity purification on immobilized
GST-UAP56 after first immunodepleting any crossreacting species
on immobilized GST-URH49. Similarly, URH49-specific antibodies
were isolated by affinity purification on immobilized GST-URH49
after first immunodepleting crossreacting species on immobilized
GST-UAP56. As shown in Fig. 1B, the affinity purified antibodies
were specific for their respective antigens. Both affinity purified
antibodies were used for the immunofluorescent staining of CaSki
cells and they detected both UAP56 and URH49 in the nucleus
with a speckled distribution (Fig. 1C). A tenfold higher concentration
of anti-URH49 antibody was required for staining. This result, along
with the western blot analysis of Fig. 1B, suggested that the crude
Fig. 1. Affinity purified anti-UAP56 and -URH49 antibodies are highly
specific. (A) HeLa and CaSki cell extracts were separated on 10% SDS-PAGE
gels probed with unfractionated peptide antibodies generated against UAP56
in rabbit. (B) Affinity purified antibodies detected GST-UAP56 but not GST-
URH49. Bacterial lysates containing either GST-UAP56 or GST-URH49 were
separated by SDS-PAGE and probed with unfractionated antiserum, which
detected both proteins. Affinity purified anti-UAP56 antibody was prepared by
passing the antiserum through a GST-URH49 affinity column to remove cross-
reacting antibodies. The eluate was then passed through a GST-UAP56 affinity
column. Bound antibodies were eluted with glycine HCl, pH 2.0. After affinity
purification, the anti-UAP56 antibody detected only GST-UAP56 but not GST-
URH49. (C) Affinity purified antibodies against GST-UAP56 and GST-
URH49 show that both proteins are located at RNA-splicing speckled
domains. HeLa cells were permeabilized, fixed and stained with affinity
purified antibodies. (D) HeLa cells were treated with a pool of four siRNA
oligonucleotides against UAP56. After 76 hours of treatment, the cells were
fixed and immunostained with affinity purified antibodies against UAP56.
This treatment removed all detectable UAP56 within the nucleus,
demonstrating the high specificity of affinity purified antibody. Both
micrographs were collected at the same microscope settings. They are
presented as moderately overexposed to show that about 10% of UAP56
remains even after knockdown. Scale bars: 10 μm. (E) The affinity purified
anti-UAP56 antibody was used to probe a western blot of protein extracts
either from MCF-10A cells treated with a UAP56-specific shRNA knockdown
for 76 hours or from control cells. The antibody signal was greatly reduced in
the knockdown cells.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1528
antiserum had a greater affinity for UAP56. Immunostaining with
antiserum and with affinity purified anti-UAP56 antibodies was
indistinguishable by both confocal or electron microscopy in HeLa
and CaSki cells, showing that the cellular localization of these
similar proteins was the same (data not shown). After using siRNA
oligonucleotides to knock down UAP56 levels, but not URH49
levels, immunofluorescent staining with the affinity purified anti-
UAP56 antibody was strongly reduced (Fig. 1D). This confirmed
the specificity of the antibody for microscopy. After an shRNA-
knockdown specific for UAP56 (Kapadia et al., 2006), the western
blotting signal generated by the affinity purified antibody was
strongly reduced (Fig. 1E).
UAP56 extends outside RNA-splicing speckled domains
Immunofluorescent localization with anti-UAP56 antibodies and
confocal microscopy showed that UAP56 was most concentrated
in and around RNA-splicing speckled domains (Fig. 2). Inside
speckled domains, it colocalized with SRm160, another RNA-
splicing and EJC protein (Blencowe et al., 2000; Blencowe et al.,
1998; Le Hir et al., 2000b). However, whereas SRm160 was more
confined to the speckled domain itself, UAP56 was also enriched
in the region around the speckled domain. This is illustrated in Fig.
2B, which presents line scans through six randomly selected
Journal of Cell Science 121 (9)
speckled domains of the confocal overlay image of Fig. 2A. The
profiles of UAP56 (green) across all the speckled domains are
broader than those of SRm160 (red). Similar localizations were
observed for EGFP-UAP56 and mRFP-SRm160 expressed in cells;
both fluorescent fusion proteins colocalized well with their
corresponding endogenous proteins (data not shown). Similar
results were obtained for cells stained for UAP56 and with SC-35
to mark speckled domains (supplementary material Fig. S1).
The higher concentration of UAP56 in regions at the periphery
of speckled domains was especially evident by electron microscopy
(Fig. 3B). At this resolution, each speckled domain consists of an
interchromatin granule cluster surrounded by a region enriched in
the perichromatin fibrils, which contain many new RNA transcripts
(Cmarko et al., 1999; Monneron and Bernhard, 1969). Interestingly,
gold beads marking UAP56 were usually present as single beads
inside clusters but were often seen in bunches at the periphery. A
majority of pre-mRNA transcripts are spliced at or near the
periphery of speckled domains (Smith et al., 1999), consistent with
the localization of UAP56, and some mRNAs actually move into
the interior of these domains before release to the cytoplasm
(Shopland et al., 2002).
The mitotic choreography of UAP56
The proteins of RNA-splicing speckled domains segregate to
different locations during mitosis before reassembling into structures
resembling interchromatin granule clusters at sites outside the
reforming nucleus (Ferreira et al., 1994). HEL25E, the Drosophila
ortholog of UAP56, is essential for normal mitotic spindle assembly
in S2 cells, an unexpected result emerging from a genome-wide
RNA interference screen (Goshima et al., 2007). Decreasing
HEL25E levels results in chromosome misalignment and elongated
spindles.
We followed the redistribution of UAP56 through mitosis in HeLa
cells, as shown in supplementary material Fig. S2. In all interphase
cells, UAP56 was present in 20-40 RNA-splicing speckled domains
in the nucleus. In prophase, as chromosomes condensed and the
nucleus disassembled, UAP56 retained a speckled distribution,
although the speckles were more often at the nuclear periphery or
at the edge of condensing chromosomes, as judged by DNA-
counterstaining with DRAQ5. By metaphase, UAP56 had moved
to the poles of the mitotic spindle and to foci distributed throughout
the cytoplasm, but more concentrated around the periphery of the
chromosomes. This same distribution is observed for SRm160 at
metaphase (Wan et al., 1994), when it might interact with cohesin
(McCracken et al., 2005). UAP56 remained at the poles of the
mitotic spindle and in smaller cytoplasmic foci through anaphase
and into telophase. At telophase, the number of cytoplasmic foci
increased and the concentration of UAP56 at the residual spindle
pole was less pronounced. By cytokinesis, UAP56 was observed
in midbodies as well as in larger structures in the cytoplasm that
became entirely nuclear by the end of mitosis. The physical
association of UAP56 with the mitotic apparatus and the mitotic
defects caused by UAP56-ortholog knockdown in Drosophila
(Goshima et al., 2007) suggest that UAP56 might play a significant
role in spindle regulation.
UAP56 and SRm160 reside in the same complex at RNA-
splicing speckled domains
FRET measures the distance between two proteins and can be used
to spatially localize sites of interaction in live cells. FRET efficiency
decreases with the sixth power of the distance between two
Fig. 2. UAP56 is concentrated in RNA-splicing speckled domains and in the
regions surrounding them. (A) CaSki cells were permeabilized, fixed and
stained for both UAP56 and SRm160. Confocal microscopy showed that
UAP56 was present in RNA-splicing speckled domains, in which it
colocalized with SRm160, a well characterized RNA-splicing speckled-
domain protein (Blencowe et al., 1998). In the regions around these domains,
UAP56 was also present at high concentration, whereas SRm160 was much
more confined to the speckled domain itself. Scale bar: 10 μm.
(B) Fluorescence intensity profiles across six randomly selected RNA-splicing
speckled domains from the nucleus in A showed that SRm160 was more
confined to the speckled domains, whereas UAP56 concentrations extended
outside RNA-splicing speckled domains. The x-axis represents pixel number
along the line passing through the RNA-splicing speckled domain. The
fluorescence intensities are plotted along the y-axis.
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fluorophores and, in practice, is only measurable when the distance
between them is smaller than 10 nm (Gordon et al., 1998). Although
this distance does not assure that the two are direct binding
partners, it can establish that the two proteins are present in the
same complex. We used mRFP-SRm160 and EGFP-UAP56 as
acceptor and donor, respectively.
Analysis with the sensitized emission software of the Leica SP2
confocal system showed that EGFP-UAP56 and mRFP-SRm160
had FRET only in RNA-splicing speckled domains, with FRET
efficiencies ranging from 2 to 8% (Fig. 4A). In order to perform
these experiments without introducing artifacts, one dish of cells
was transfected with only EGFP-UAP56, a second with only mRFP-
SRm160 and a third dish with both. At 24 hours after transfection,
cells from all three cultures were trypsinized, mixed and replated
on coverslips for 24 hours before fixation. Fields in which one cell
from each of the transfection conditions was present were selected
Fig. 3. UAP56 was most concentrated at the periphery of interchromatin granule clusters. Anti-UAP56 antibody and 5 nM gold-bead-conjugated secondary
antibodies were used for the pre-embedment staining of CaSki cells with an EDTA regressive counter stain. Although UAP56 was present throughout the cluster,
the largest concentration of gold beads was at the periphery of the cluster, where interchromatin granules meet perichromatin fibrils. This is the region of the
nucleus in which the majority of transcripts are spliced and from which they are released to the cytoplasm. (A) A low-magnification view of a cell with an EDTA-
treatment time of 30 minutes. (B) A high-magnification view of the interchromatin granule cluster indicated in A. The 5-nm gold beads have been highlighted with
a yellow overlay to make them easier to distinguish.
Fig. 4. UAP56 and SRm160 are present in the same
macromolecular complexes at RNA-splicing speckled domains.
FRET between EGFP-UAP5 wt or UAP56 K95N (green) and
mRFP-SRm160 (red) was measured in transiently transfected
HeLa cells by the method of sensitized emission (Gordon et al.,
1998). (A) Cells expressing both proteins and those expressing
only EGFP-UAP56 or only mRFP-SRm160 were trypsinized and
replated on coverslips together. Fields that contained at least one
co-transfected cell and one each of the control singly transfected
cells were selected for analysis (left panel). FRET was found only
in cells expressing both EGFP-UAP56 and mRFP-SRm160; within
these cells, FRET was found only in the regions of RNA-splicing
speckled domains. FRET efficiency was calculated using Leica
confocal software. The maximum FRET efficiency between
mRFP-SRm160 and EGFP-UAP56 wt at speckled domains was
8%. FRET efficiencies are presented in a color-coded format with
a scale to the right of the right panels. (B) There was no FRET observed in RNA-splicing speckled domains between mRFP-SRm160 and EGFP-UAP56 K95N.
The maximum FRET efficiency between SRm160 and UAP56 K95N was 6%, but this was in the nucleoplasm. FRET efficiencies are presented in a color-coded
format with a scale to the right of the middle panel. Scale bars: 10 μm.
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for analysis. The reference images from control cells expressing
donor only (EGFP-UAP56) or acceptor only (mRFP-SRm160) and
the FRET images from cells expressing both were therefore
collected simultaneously under identical optical conditions and from
the same field.
When the same experiment was done with EGFP-UAP56 K95N,
a mutant that we will show does not bind ATP, and mRFP-SRm160,
there was a lower level of FRET in the nucleoplasm but no FRET
in RNA-splicing speckled domains (Fig. 4B). In the same
experiments, EGFP-Aly/REF and mRFP-SRm160 did not FRET,
and EGFP-TAP and mRFP-Y14 did not FRET. Although positive
FRET is evidence that two proteins are in the same complex, the
absence of FRET is difficult to interpret; two proteins could be
sufficiently close but their fluorescent domains might be in the
wrong orientation.
These FRET results are consistent with the presence of SRm160
and UAP56 in the same multi-protein complexes located at RNA-
splicing speckled domains. Studied in vitro, both proteins can be
assembled into RNA-splicing complexes (Blencowe et al., 2000;
Blencowe et al., 1998; Blencowe et al., 1994; Fleckner et al., 1997)
and are both resident in the EJC (Gatfield et al., 2001; Le Hir et
al., 2000a; Le Hir et al., 2000b). Their co-residency in the protein
complexes of real cells gives greater biological relevance to those
in vitro results.
A point mutation in UAP56 abolishes ATP binding and reduces
the spatial association with specked domains
We have previously shown that SRm160 has an ATP-dependent
FRAP recovery at RNA-splicing speckled domains (Wagner et al.,
2004). Because SRm160 does not have an ATP-binding site, we
hypothesized that other proteins would mediate the ATP-dependent
incorporation of SRm160 into complexes at speckled domains.
SRm160 and UAP56 are present in the same complexes, as shown
by extensive in vitro results and by our FRET results (Fig. 4).
Because UAP56 has an ATP-binding site, we hypothesized that
UAP56 could be the mediator for the ATP-dependent mobilization
of SRm160 from RNA-splicing speckled domains. To test this
hypothesis, we made a point mutation in the ATP-binding site of
UAP56 – a single Lysine to Asparagine substitution at amino acid
95. The crystal structure of UAP56 with bound MgADP (Shi et al.,
2004; Zhao et al., 2004) shows that the positively charged Lysine-
95 sidechain binds via hydrogen bonds to the oxygen atoms of the
β-phosphate of the nucleotide. The same point mutation in the
Saccharomyces cerevisiae ortholog of UAP56, Sub2p, has
previously been used to eliminate ATP binding (Zhang and Green,
2001).
Journal of Cell Science 121 (9)
As shown in Fig. 5, the K95N mutation dramatically reduced
ATP binding. Adopting a method originally used for the DEAD-
box helicase eIF4A (Pause and Sonenberg, 1992), GST-UAP56 or
GST-UAP56 K95N were incubated with αP32-ATP and the
nucleotide was crosslinked to the active site by ultraviolet
irradiation. After SDS-PAGE, the amount of labeled ATP
crosslinked to the active site was measured.
The localization of the EGFP-UAP56 K95N mutant was
determined by confocal microscopy (Fig. 6). When compared to
the wild-type protein, the mutant was more uniformly distributed
in the nucleus and not as concentrated at speckled domains. This
suggested that UAP56-binding at speckled domains was ATP-
dependent. This mutant of UAP56, although not entirely excluded
from speckled domains, had no measurable FRET with mRFP-
SRm160 at speckled domains (Fig. 4).
Fluorescence recovery after photobleaching
The use of fluorescent fusion proteins makes it possible to
characterize the binding and diffusion of proteins within living cells
using FRAP and related techniques. For most proteins, fluorescence
recovery rates are limited by binding kinetics, which are slower
than rates of diffusion (Lele et al., 2004; Lele et al., 2006;
Nickerson, 1998). For reference, when considering FRAP results,
the half-time (t1/2) for the diffusion-limited recovery of EGFP in
the nucleus is about 0.2-0.3 seconds (Kruhlak et al., 2000).
When EGFP-UAP56 was expressed in HeLa cells and then the
cells were either examined live or fixed before confocal
microscopy, it colocalized with the endogenous UAP56 in RNA-
splicing speckled domains and also in the region around the
speckled domains. This was also the distribution in live cells co-
expressing EGFP-UAP56 and mRFP-SRM160. We evaluated the
degree of overexpression after transfection by conducting
immunofluorescent staining of cells with an affinity purified anti-
Fig. 5. A point mutation in the ATP-binding domain of UAP56 inhibits ATP
binding. A Lysine 95 to Asparagine mutation in the ATP-binding domain of
GST-UAP56 was made. Using a method applied to previous DEAD-box
helicases (Pause and Sonenberg, 1992), GST-UAP56 wt or GST-UAP56 K95N
was UV-cross-linked to bound α-P32-ATP in the presence or absence of 0.1
OD260 units of polyU. The bound and unbound α-P32-ATP were separated on
a 12% SDS-PAGE gel before phosphoimaging. The binding of α-P32-ATP
was strongly reduced by the mutation but unaffected by polyU.
Fig. 6. EGFP-UAP56 K95N was present in higher concentrations in regions
outside of the RNA-splicing domains, compared with EGFP-UAP56 wt. HeLa
cells were transfected with either EGFP-UAP56 wt or EGFP-UAP56 K95N.
At 24 hours after transfection, the cells were fixed, permeabilized and
immunostained for endogenous UAP56. Compared with UAP56 wt, UAP56
K95N was less constrained to speckled domains and a higher fraction was
present in regions outside the RNA-splicing speckled domains compared with
cells expressing UAP56 wt. When stained for endogenous UAP56 protein
using affinity purified anti-UAP56 antibody, both proteins localized to RNA-
splicing speckled domains along with endogenous UAP56 proteins. Scale bars:
10 μm.
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UAP56 antibody that recognized both endogenous UAP56 and
EGFP-UAP56, and with an Alexa-Fluor-568-conjugated secondary
antibody. Total nuclear Alexa-Fluor-568 fluorescence in individual
cells was quantified. In relative fluorescence units, EGFP-UAP56-
expressing cells had a mean fluorescence of 304±51 (n=10),
whereas non-expressing cells had a total fluorescence of 256±11
(n=10). Therefore, the expression of EGFP-UAP56 increased total
UAP56 levels by 18.9%.
The binding of UAP56 at RNA-splicing speckled domains was
measured in live cells by FRAP of EGFP-UAP56. As shown in
Fig. 7A, EGFP-UAP56 recovered at speckled
domains with a t1/2 of 15.5 seconds. The immobile
fraction of 22.5% represented a more tightly bound
fraction that did not exchange over the time course
of the experiment. We saw no recovery gradient
across the bleach zone, consistent with diffusion
being much faster than binding or unbinding (Lele
et al., 2004). In early experiments, similar recovery
curves were obtained for spot and region-of-interest
photobleaching, so we routinely used spot
photobleaching. We concluded that the recovery rates
for both fusion proteins, expressed separately or
together, were too slow to be diffusion-limited
(Kruhlak et al., 2000; Lele et al., 2004; Lele et al.,
2006) and, therefore, the experiment was actually
measuring rates of protein exchange at relatively
immobile binding sites.
By comparison, EGFP-UAP56 in the nucleoplasm
away from speckled domains recovered after spot
photobleaching, with a recovery t1/2 of 8.8 seconds
and an immobile fraction of only 2.5% (n=10, data
not shown).
The point mutant EGFP-UAP56 K95N, which had
greatly reduced ATP binding, was much less
concentrated in and around RNA-splicing speckled
domains. It was also less tightly bound to nuclear
structures. The mutant had a recovery t1/2 of 4.09
seconds with an immobile fraction of 19.1% (Fig.
7A).
We observed a rapid partial decrease in
fluorescence intensity outside the bleach zone and
this was larger for the mutant protein. This represents
a hyperdynamic fraction of protein that is either
unbound or very loosely bound (Meshorer et al.,
2006). Measured at 2 seconds after the photobleach,
Fig. 7. The FRAP mobility of EGFP-UAP56, but not its
K95N mutant, is ATP-dependent. HeLa cells were
transfected with EGFP-UAP56 wt or EGFP-UAP56 K95N.
After 24 hours, a nuclear region of interest (white square)
was photobleached for 3 seconds using maximum laser
intensity at 488 nm. The fluorescence recovery of EGFP-
UAP56 or its K95N mutant in the bleached zone was
recorded. In live cells, the fluorescence of both proteins
recovered after photobleaching, showing that UAP56 was
exchanging on binding sites at speckled domains. After
digitonin permeabilization, the FRAP recovery of EGFP-
UAP56 stopped. By contrast, after digitonin
permeabilization, EGFP-UAP56 K95N recovered after
photobleaching, showing that its exchange at speckled-
domain binding sites continued. Addition of 1 mM ATP
restored FRAP recovery to EGFP-UAP56, showing that the
FRAP mobility, that is the exchange at speckled-domain
binding sites, is ATP-dependent. (A) A single cell for each
experiment is shown before and after the photobleach, and
then at one recovery time point. Scale bars: 10 μm. (B) The
calculated recovery curves for all cells in each experiment
are shown, with the number of cells (n) noted on each graph.
Means are plotted with error bars for standard deviations.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1532
the UAP56 K95N mutant had a hyperdynamic fraction of
32.6±12.9% (n=10), whereas, for wild-type UAP56, it was only
18.4±11.0% (n=10). This change in the size of the rapidly moving
pool and the lack of concentration of the K95N mutant at speckled
domains suggests that UAP56 binding at speckled domains requires
ATP binding.
The UAP56 K95N mutant had a small effect on FRAP recovery
rates of mRFP-SRm160 in cells expressing both proteins. mRFP-
SRm160 and EGFP-UAP56 K95N, the ATP-binding deficient
mutant of UAP56, were co-expressed in HeLa cells. After 16 hours,
the binding of SRm160 at RNA-splicing speckled domains was
measured in live cells by FRAP (Fig. 8). In cells expressing mRFP-
SRm160, recovery had a t1/2 of 16.3 seconds, similar to the rate of
EGFP-SRm160 recovery (Wagner et al., 2004). The immobile
fraction was 11%, and this represents a fraction of SRm160 that was
Journal of Cell Science 121 (9)
so tightly bound that it did not exchange over the time course of the
experiment.
Co-expression with either wild-type EGFP-UAP56 (EGFP-
UAP56 wt) or the EGFP-UAP56 K95N mutant increased the size
of the immobile fraction of mRFP-SRm160 (Fig. 8). This was
22% of the mRFP-SRm160 for cells co-expressing EGFP-UAP56
wt and 27.5% for cells also expressing EGFP-UAP56 K95N.
In the presence of either EGFP-UAP56 wt or mutant EGFP-
UAP56 K95N, mRFP-SRm160 recovered with a t1/2 of 6.1
seconds. This was more than twice as fast as in control cells
expressing neither form of UAP56 (Fig. 8B). There was no
significant difference between the recovery curve for mRFP-
SRm160 in the presence of EGFP-UAP56 wt compared to the
recovery of mRFP-SRm160 in the presence of EGFP-UAP56
K95N (P<0.995).
UAP56 K95N does not affect the
ATP-dependence of SRm160 binding
We have developed a novel assay for
measuring the effects of small molecules on
the binding of fluorescent fusion proteins in
nuclei (Wagner et al., 2004). In this ‘in vitro
FRAP’ technique, cells are permeabilized with
digitonin, which leaves the nuclear envelope
intact. Small molecules diffuse through
nuclear pores, while the nuclear envelope
retains larger molecules and their complexes.
Thus, small molecules can be easily removed
or added back. Using this technique, we
showed that ATP quickly leaves the nucleus
after digitonin permeabilization (Wagner et al.,
2004). As a result, EGFP-SRm160 does not
recover when photobleached at speckled
domains in the nuclei of digitonin-treated
cells. Adding back ATP restores recovery,
Fig. 8. UAP56 does not mediate the ATP-dependent
intra-nuclear mobility of SRm160. HeLa cells were
co-transfected with mRFP-SRm160 and either
EGFP-UAP56 wt or EGFP-UAP56 K95N. After 24
hours, the mRFP-SRm160 in a nuclear region of
interest (white square) was photobleached for 3
seconds using maximum laser intensity at 568 nm.
The recovery of mRFP-SRm160 in the bleached
zone was recorded. The cells were later
permeabilized with digitonin, which permeabilizes
the cell membrane but leaves the nuclear envelope
intact. When digitonin-permeabilized cells were
photobleached, there was no recovery of
fluorescence in the bleached zone (data not shown)
(Wagner et al., 2004). Adding back 1 mM ATP
restored fluorescence in cells expressing either wild-
type UAP56 or UAP56 K95N. The ATP-
dependence of SRm160 exchange at speckled
domains did not depend on the ability of UAP56 to
bind ATP. (A) A single cell for each experiment is
shown before and after the photobleach, and then at
one recovery time point. Scale bars: 10 μm. (B) The
calculated recovery curves for all cells in each live-
cell experiment are shown with the number of cells
noted on each graph. (C) Matching calculated
results for in vitro FRAP experiments in which the
cells were digitonin-permeabilized before
photobleaching. The error bars are standard
deviations.
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showing that the exchange of SRm160 at speckled domains requires
ATP. Because SRm160 does not have an ATP binding site and since
it is in complexes with UAP56 which does have an ATP-binding site,
we hypothesized that UAP56 might mediate the ATP-dependent
binding of SRm160 at speckled domains.
After digitonin permeabilization to remove ATP, mRFP-SRm160
did not recover after photobleaching at speckled domains. This was
consistent with the results we have previously reported for EGFP-
SRm160 (Wagner et al., 2004). Photobleach recovery could be
restored by adding back 1 mM ATP (Fig. 8). There was no effect
on the ATP-dependence of SRm160 recovery when EGFP-UAP56
or EGFP-UAP56 K95N were also present. The ATP-dependent
recovery of mRFP-SRm160 was slightly faster in the cells expressing
EGFP-UAP56 K95N (t1/2=13.1 seconds) than in the cells expressing
the wild-type EGFP-UAP56 (t1/2=15.5 seconds). The immobile
fractions were similar after ATP supplementation and were about
20%.
In earlier experiments, we observed no effect on the ATP-
dependent FRAP recovery of EGFP-SRm160 in live cells after
partial RNAi knockdown (Fig. 1D) of UAP56 (data not shown).
Knockdown of UAP56 alone is, however, insufficient to strongly
inhibit mRNA export, apparently because it can be replaced by
URH49 (Kapadia et al., 2006).
The binding of wild type UAP56 at speckled domains requires
ATP
The UAP56 in live cells was in rapid equilibrium between a
diffusing pool and a fraction bound at RNA-splicing speckled
domains; the t1/2 of exchange on speckled domains was 15.5 seconds
(Fig. 7). However, after permeabilization of the nuclear envelope,
UAP56 remained tightly bound at speckled domains and was not
removed even after 5 minutes (Fig. 2). This discrepancy suggested
that UAP56 binding and exchange at speckled domains might
require a cofactor that was removed by permeabilization. Because
UAP56 K95N, which did not bind ATP, did not localize well to
speckled domains (Fig. 6), the likely cofactor was ATP. The in vitro
FRAP assay was used to test the hypothesis that ATP was required
for the exchange UAP56 at speckled domains (Fig. 7). In digitonin-
permeabilized cells, which are depleted of ATP (Wagner et al.,
2004), EGFP-UAP56 did not recover after photobleaching. When
1 mM ATP was added back, recovery was restored with a t1/2 of
16.4 seconds and an immobile fraction of 34.4%. Because the
UAP56 K95N mutant, which cannot bind ATP, does not concentrate
in speckled domains, we conclude that ATP is affecting the on-rate
constant for UAP56 binding in complexes at speckled domains.
RNA export to the cytoplasm requires binding of ATP to
UAP56
UAP56 and its orthologs are essential mRNA export factors in yeast,
Drosophila, Xenopus and human cells (Gatfield et al., 2001; Jensen
et al., 2001; Kapadia et al., 2006; Luo et al., 2001; Strasser and
Hurt, 2001). To test the hypothesis that UAP56 ATP-binding activity
is required for the export of mRNA, we transiently transfected 293T
cells with an intron-containing β-globin minigene and either wild-
type EGFP-UAP56 or the EGFP-UAP56 K95N mutant. After 24
hours, cytoplasmic and nuclear RNA was separated and extracted.
Using quantitative reverse transcriptase (RT)-PCR, the relative
concentrations of spliced and unspliced β-globin RNA were
measured in each fraction. As shown in Fig. 9A, cells expressing
the ATP-binding mutant, UAP56 K95N, accumulated spliced β-
globin mRNA in their nuclei to a level 15-fold higher than in nuclei
of cells expressing wild-type UAP56. The level of unspliced β-
globin RNA in the nucleus was not significantly changed by the
K95N mutant (Fig. 9B).
In previous work, the knockdown of UAP56 caused some
nuclear accumulation of poly(A) RNA (Kapadia et al., 2006). The
inhibition of mRNA export was stronger when both UAP56 and
the related protein URH49 were knocked down, showing that the
two proteins can perform redundant functions in RNA export. The
double knockdown was quickly lethal. The results that we report
here are consistent with ATP playing an essential role in the RNA-
export function of UAP56. The effect of expressing UAP56 K95N
was much greater than that of knocking down UAP56, suggesting
that the UAP56 K95N mutant has a dominant-negative effect,
affecting both the UAP56 and the URH49 RNA-export mechanisms.
Discussion
UAP56 is concentrated in splicing speckled domains but is also
enriched in the surrounding perispeckle region (Figs 2, 3). This is
consistent with a role for UAP56 in RNA splicing and export,
because a majority of transcripts are spliced in sites at or near
splicing speckled domains (Smith et al., 1999). Imaged by electron
microscopy, each domain consists of a cluster of granules called
an interchromatin granule cluster surrounded by a region enriched
in perichromatin fibrils (Monneron and Bernhard, 1969). The
Fig. 9. UAP56 K95N has a dominant-negative effect on RNA export. 293T
cells were co-transfected with a β-globin-splicing reporter plasmid and
EGFP-UAP56 wt or EGFP-UAP56 K95N expression vector. 24 hours after
transfection, the RNA of the cells was separated into cytoplasmic and
nuclear fractions. Real-time PCR with primers recognizing the 5 exon and
3 exon was performed. (A) In cells expressing EGFP-UAP56 K95N,
there was a 15-fold increase of β-globin in the nuclear fraction compared
with cells expressing EGFP-UAP56 wt. (B) When the nuclear PCR product
was separated on a 1% agarose gel it was all spliced, showing that the
nuclear accumulation is due to reduced mRNA export and not pre-mRNA
splicing.Jo
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clusters contain high concentrations of RNA-splicing factors
(Lamond and Spector, 2003; Mintz et al., 1999; Saitoh et al., 2004),
whereas perichromatin fibrils contain many new RNA transcripts
(Biggiogera and Fakan, 1998; Cmarko et al., 1999). Some mRNAs
might traffic through both regions, moving from the periphery into
the interior of a speckled domain before release to the cytoplasm
(Shopland et al., 2002).
In vitro assays have previously shown that UAP56 and SRm160
are both present in spliceosomes and are both present in the EJC,
which is proposed to facilitate efficient RNA export out of the
nucleus. Here, we used FRET to establish the presence of both
proteins in the same complexes located at RNA-splicing speckled
domains of the nucleus (Fig. 4). The formation of complexes of
proteins implicated in RNA export has not previously been
established by FRET. FRET between two fluorophores occurs only
when the distance between them is in the range of 1-10 nM (Gordon
et al., 1998). At this distance, we can be assured that both proteins
are present within the same complex. Bimolecular fluorescence
complementation has been used to show that two other EJC
proteins – Y14 and NXF1 (TAP) – inhabit the same complex in
cells (Schmidt et al., 2006). Bimolecular complementation provides
a stronger signal but, because it requires a more stable complex in
which fluorescence develops over a period of one to several hours,
more dynamic events might be missed.
FRET between EGFP-UAP56 and mRFP-SRm160 occurred only
within RNA-splicing speckled domains and with a maximum
FRET efficiency of 8%. This is a high efficiency for this technique
and suggests that the two proteins are close together within the same
complex. FRET can be difficult to establish because it depends on
the distance between, orientation of and environment of the two
molecules. However, the importance of attempting to establish
which complexes exist in cells, and at which sites, is emphasized
by a recent proteomic study identifying proteins co-
immunoprecipitating with anti-SRm160 antibodies (McCracken et
al., 2005). There were 110 co-immunoprecipitating proteins
identified. Theoretically, by including a single SRm160 molecule
in each complex, we could assemble 110 different dimers, 12,100
different trimers, more than 1.3 million tetramers, and so on. It is
important to supplement the powerful techniques of in vitro
biochemistry with experimental approaches that detect complexes,
such as the one including UAP56 and SRm160, that actually form
in cells.
The physical chemistry of binding – including the measurement
of kinetic parameters, of equilibrium constants and of the sizes of
bound versus diffusing pools – is readily studied in live cells by
the complimentary technique of FRAP or its variants (Kruhlak et
al., 2000; Lele et al., 2004; Lele et al., 2006; Lele and Ingber, 2006;
Phair and Misteli, 2000; Phair et al., 2004; Stenoien et al., 2001).
FRAP has shown that the binding of other RNA-splicing factors
and RNA-export factors in splicing speckled domains is dynamic
(Kruhlak et al., 2000; Phair and Misteli, 2000; Wagner et al., 2004).
Factors cycle into and out of speckles, although the shape and
position of the speckles remains constant over time periods of many
minutes. We report similar behavior for UAP56.
UAP56 binds and hydrolyses ATP (Shi et al., 2004). We
engineered a point mutation in the ATP-binding site of UAP56 that
inhibited ATP binding (Fig. 5). This UAP56 K95N mutant did not
affect mRNA splicing, but had a dominant-negative effect on nuclear
export of mRNA (Fig. 9). The mechanism for this effect on mRNA
export might be that the binding of ATP to UAP56 is required for
UAP56 incorporation into mRNA-export complexes at RNA-
splicing speckled domains. First, the K95N mutation in the ATP-
binding site made the protein less concentrated in RNA-splicing
speckled domains (Fig. 6). Second, during in vitro FRAP
experiments, wild-type UAP56 did not recover after photobleaching
in the absence of ATP (Fig. 7). Photobleach recovery was restored
by adding back ATP, and with kinetics similar to those seen in live
cells. Expression of this mutant UAP56 did not change the ATP-
dependence of SRm160 binding at RNA-splicing speckled domains
(Fig. 8), even though UAP56 and SRm160 were present in the same
complexes (Fig. 4).
The simplest model we can propose based on the FRET and
FRAP results we report here, supplemented by previous in vitro
results, is that UAP56, SRm160 and RNPS1 are present in the same
complex at speckled domains and that the assembly of this complex
has two ATP-dependent steps: one for the incorporation of UAP56
in the complex and a second for the incorporation of SRm160. The
first step is mediated by the binding of ATP to UAP56, whereas
the second is mediated by the binding of ATP to a factor that is yet
to be identified. Assembly of the complex is required for mRNA
export.
Recent advances in microscopy have given us a new set of tools
for studying biochemistry in real cells. We recommend in vitro
FRAP as an additional tool for identifying cofactors, such as ATP,
that are required for complex assembly and disassembly. With the
complimentary use of protein knockdowns, protein mutations and
cofactor analogs, the in vitro FRAP technique allows us to probe
deeper into the mechanisms of complex assembly in the context of
a real cell.
Materials and Methods
Constructs
GST-UAP56 and GST-URH49 vectors (Kapadia et al., 2006) were a gift from Lee
Johnson (Ohio State University, Columbus, OH). For generating green fluorescent
UAP56, the cDNA was amplified by high fidelity PCR, sequenced, and then cloned
into EGFP C1 vector (Clontech). Similarly, the mRFP-SRm160 was generated by
amplifying the cDNA as above and transferred into an expression vector containing
mRFP. Briefly, the vector was based on EGFP-C2 (Clontech) but with the EGFP
replaced with mRFP from a cDNA provided by Roger Tsien (University of California,
San Diego, CA).
UAP56 K95N with a point mutation in the UAP56 ATP-binding site was made
using a Stratagene QuikChange site-directed mutagenesis kit. Mutations at desired
sites were confirmed by DNA sequencing.
Transfections
HeLa cells (at ~75% confluence) on 2222-mm coverslips were transfected with 6
μg of plasmid DNA encoding EGFP-UAP56 wt or EGFP-UAP56 K95N and/or mRFP-
SRm160 using 15 μl of Lipofectamine 2000 per coverslip in 1 ml of Optimem
(GiboBRL, Life Science Research, Paisley, UK) for 4 hours and then the medium
was replaced with DMEM complete medium with 10% FBS. After overnight culture,
the transfection efficiency was >75%.
Generation of UAP56 antibodies
A hexadecapeptide contained within human UAP56 (GAEAPAKKDVKGSYVC) was
synthesized and coupled to Keyhole Limpet Hemocynanin (SynPep, Dublin, CA).
Rabbit antiserum was prepared by Covance (Denver, PA).
Affinity purification of antibodies
The GST-UAP56 and GST-URH49 fusion proteins were purified and bound to
Glutathione-Sepharose 4B beads (Novagen) as described previously (Pryor et al.,
2004), except that the volume of beads used was 100 μl. The protein-bound resins
were washed three times with cross-linking buffer (200 mM HEPES, pH 8.5) and
then cross-linked with 2 ml of 20 mM Dimethy Pimelimidate (Sigma) in cross-linking
buffer for 1 hour at room temperature. The cross-linking solution was removed by
centrifugation at 500 g for 2 minutes and residual cross-linker was neutralized by
adding 2 ml of 200 mM Ethanolamine (Sigma) for 30 minutes at room temperature.
Non-covalently bound molecules from the resin were removed by washing twice
with 2 ml of glycine elution buffer (150 mM NaCl, 200 mM Glycine-HCl, pH 2.0).
Finally, the resin was washed with 10 ml of TBS twice at 4°C. The antibodies were
diluted with 1:1 TBS and mixed with GST cross-linked resin for 30 minutes at 4°C.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1535ATP binding to UAP56
The unbound antibodies were removed by centrifugation at 500 g for 2 minutes. The
resin was washed with 5 volumes of TBS, and with 10 volumes of wash buffer (500
mM NaCl, 20 mM Tris, pH 7.4, 0.1% Triton X-100). The antibodies were eluted
with 2 ml of glycine elution buffer.
Immunocytochemistry
To prepare cells for immunofluorescent localization experiments, two different
methods were applied:
(1) Fixation/permeabilization: cells were washed in PBS before fixation with 4%
formaldehyde in cytoskeletal buffer (10 mM Pipes, pH 6.8/300 mM sucrose/100 mM
NaCl/3 mM MgCl2/1 mM EGTA) for 50 minutes. To improve antibody penetration,
the cells were then permeabilized using 0.5% Triton X-100 in cytoskeletal buffer for
5 minutes. All steps were performed at 4°C.
(2) Permeabilization/fixation: after washing in PBS, cells were incubated in 0.5%
Triton X-100 in cytoskeletal buffer for 2-5 minutes. This step removes soluble proteins
from both the cytoplasm and nucleus. Cells were later fixed in 4% formaldehyde in
cytoskeletal buffer for 50 minutes. All steps were performed at 4°C.
Antibody staining: cells were stained with antibodies as described (Wagner et al.,
2003) and, unless otherwise specified, imaged with a Leica SP1 laser scanning
confocal microscope. The B1C8 monoclonal antibody against SRm160 is available
from Calbiochem/EMD. The SC-35 monoclonal was from Sigma. Line profiles
through speckled domains were measured using ImageJ.
Western blots
Proteins from HeLa and CaSki cell lysates were separated by 10% SDS Gel
electrophoresis, and transferred to nitrocellulose membranes. Western blots were
performed using primary antibodies raised against UAP56 in rabbit or affinity purified
URH49 or UAP56 antibodies, followed by Goat anti-rabbit horseradish peroxidase
conjugated secondary antibodies, and developed with SuperSignal West Pico
Chemiluminescent Substrate (Pierce, Rockford, IL).
Pre-embedment electron microscopic localization of UAP56
CaSki cells were grown on Thermanox coverslips (Nunc). The cells were washed at
4°C in PBS, permeabilized with cytoskeletal buffer containing 0.5% Triton X-100,
2 mM VRC (vanadyl ribonucleoside complex) and 1 mM AEBSF [4-(2-aminoethyl)-
benzenesulfonyl fluoride, hydrochloride] at 4°C for 5 minutes, fixed in 4%
paraformaldehyde (Ted Pella) in cytoskeletal buffer containing VRC and AEBSF at
4°C for 40 minutes, washed twice in cytoskeletal buffer at 4°C, then antibody-stained
with a rabbit antibody against UAP56. Control sections were not exposed to the first
antibody. The second antibody was linked to 5-nm gold beads (Nickerson et al., 1990).
Cells were then fixed with 2.5% glutaraldehyde (Ted Pella) in 0.1 M Sörensen’s
phosphate buffer, pH 7.3 (Glauert, 1991) at 4°C for 1 hour, then washed twice in the
same buffer and held overnight at 4°C in the buffer. Cells were dehydrated in a graded
series of ethanol solutions with propylene oxide as the intermediate solvent, infiltrated
with and embedded in Epon/Araldite, and cured at 60°C for 2 days. The coverslips
were removed and thin sections were cut. The sections were EDTA regressively stained
(Bernhard, 1969) with 5% uranyl acetate for 3 minutes, 0.2 M EDTA for 30-60 minutes
and then lead-citrate stained (Knight, 1982) for 2.5 minutes. Sections were imaged
with a Philips CM10 electron microscope with a Gatan ES1000W Erlangshen CCD
Camera.
Fluorescence recovery after photobleaching
FRAP was performed at 37°C as described previously (Wagner et al., 2004). Routinely,
two images were taken before and 20-30 images were taken after the bleach at intervals
of 1-20 seconds depending on the time of recovery. To destroy EGFP fluorescence,
maximal laser power was applied to a region of interest for 3 seconds. Confocal
Software (version 2; Leica Microsystems) was used to measure the intensity of
fluorescence in the bleached area and in the whole nucleus for the whole stack of
images. For analysis, these data were transferred into a Microsoft Excel spreadsheet.
Any remaining fluorescence in the bleached area after the bleach was normalized to
zero. The relative fluorescence intensity (Irel) in the bleached area was calculated as
described previously (Phair and Misteli, 2000). Irel=T0 If/Tt I0, with T0 being the total
cellular fluorescence before bleach, Tt the total cellular fluorescence at time t, I0 the
fluorescence in the bleached area before bleach, and If the fluorescence in the bleached
area at time t. Recovery curves were drawn using Kaleidagraph 3.5 (Synergy
Development). The percentage of immobile protein was determined after
normalization of fluorescence in the bleached area to 0 in the first post-bleach image
and 1 in the pre-bleached image, and it was calculated as the percentage difference
between the relative fluorescence asymptote of the recovery curve and a relative
recovery of 1, a value that would reflect complete recovery without an immobile
fraction. For example, an asymptote at 0.8 reflects an immobile fraction of 20%.
Curve-fitting for graphic presentation was performed as described previously (Liu et
al., 2005). Individual time points are presented as means with error bars showing
standard deviations. Half times of recovery were obtained from individual fitted
recovery curves when the relative recovery reached half of the plateau value minus
the initial value after the bleach.
In vitro FRAP assays
We have previously reported the development of an assay for measuring the effect
that molecules small enough to diffuse through nuclear pores have on the binding of
nuclear proteins to nuclear structures such as chromatin or RNA-splicing speckled
domains (Wagner et al., 2004). Fluorescent-protein-expressing cells were grown on
40-mm diameter circular coverslips. After viewing coverslips in a Bioptechs FCS2
live-cell chamber on the Leica SP1 confocal microscope with a Bioptechs objective
heater, cells were perfused with permeabilization buffer (20 mM HEPES, pH 7.3;
110 mM potassium acetate; 2 mM magnesium acetate). Cells were then permeabilized
by perfusion with 50 μg/ml digitonin in permeabilization buffer for 6 minutes. After
incubation, the cells were washed again with permeabilization buffer. FRAP kinetic
measurements were made as described above. To examine the effect of ATP on the
recovery of fluorescent-tagged proteins, a stock solution of 1 mM ATP was freshly
made in permeabilization buffer with the pH readjusted to 6.8. Different ATP
concentrations in permeabilization buffer were perfused onto digitonin-permeabilized
cells, in which ATP equilibrated across nuclear pores, and then FRAP recovery rates
for nuclear proteins were measured.
Fluorescence resonance energy transfer
FRET between EGFP-UAP56 and mRFP SRm160 was measured using the Sensitized
Emission FRET wizard in Leica SP2 confocal software. This software calculates
FRET and FRET efficiency by the method of Gordon et al. (Gordon et al., 1998)
after correction for any direct excitation of the acceptor at the donor excitation
wavelength and after correcting for the dependence of FRET on the concentration
of the acceptor.
In order to have the measured cell and the control cells in the same microscopic
field and analyze the image, we separately transfected HeLa cells with EGFP-UAP56,
with mRFP-SRm160, or with both. 24 hours later, transfected cells from all three
cultures were trypsinized, mixed and replated on 22-mm coverslips for another 24
hours before fixation. The reference images from control cells expressing donor only
(EGFP-UAP56) and acceptor only (mRFP-SRm160), and the FRET images from
cells expressing both, were therefore collected simultaneously under identical optical
conditions. Spectral overlap, optical cross-talk and differential expression levels of
the fluorophores in the transfected cells were corrected for in the program by making
measurements from the control cells in the same field (Gordon et al., 1998). The
contributions of the background noise and spectral overlap were removed on a pixel-
by-pixel basis in calculating the FRET signal in the doubly transfected cell in the
same field. While collecting the images, the laser intensities were kept constant.
Photomultiplier gain and offsets were selected so that fluorescence was within the
linear range of detection, and this was checked for each control and FRET cell. EGFP
was excited at 488 nm, whereas mRFP was excited with a laser line at 562 nm.
RNA interference
The siRNA duplexes (Smartpool, Dharmacon, Lafayette, CO) were transfected into
HeLa cells using Oligofectamine (Invitrogen, Carlsbad, CA) as recommended by the
manufacturer. siRNA duplexes, at a concentration of 10 nM, were introduced once
on day 0 and again after 48 hours, and were assayed after 72 hours. For MCF-10A
cells, an inducible knockdown was engineered using a two-lentivirus system (Szulc
et al., 2006; Wiznerowicz and Trono, 2003) expressing an shRNA against UAP56
(Kapadia et al., 2006) under doxycycline induction. Cells were sorted for
bicistronically expressed EGFP and dsRED and induced with 500 nm doxycycline.
At 76 hours after doxycycline treatment, cell extracts were prepared and proteins
were separated on 10% SDS PAGE gel. Western blotting was performed using affinity
purified antibodies against UAP56.
Splicing reporter assay
RNA splicing was measured by a reporter assay in cells transfected with a human
β-globin minigene, a generous gift from Benjamin Blencowe and Susan McCracken
(McCracken et al., 2002). 293T cells were grown on 10-cm culture dishes to 90%
confluence. 6 μg of β-globin-minigene-containing plasmid and 6 μg of EGFP-tagged
UAP56 wt and/or UAP56 K95N were transfected into cells using 15 μl of
Lipofectamine 2000 in serum-free Optimem. After 24 hours the cells were washed
with PBS, and cytoplasmic and nuclear extracts were prepared with a Qiagen RNeasy
kit according to kit instructions, except that the nuclear fraction was washed an extra
time with 10 volumes of lysis buffer to minimize cytoplasmic contamination. After
separating cytoplasmic and nuclear fractions, the total RNA from each fraction was
extracted with 1 ml of TRIZOL (Invitrogen). Real-time PCR was performed using
a DNA Engine Opticon System (MJ Research). The primers for β-globin minigene
were in exon 1 and exon 2. The spliced or unspliced products were identified based
on the molecular weight of real-time PCR product run on 1.2% agarose gel. The
cDNA was amplified using a QIAGEN HotStarTaq Master Mix kit (QIAGEN)
containing SYBR green (Schmittgen and Zakrajsek, 2000) and using 0.1 μg of the
following primers: β-globin minigene forward primer, 5-ATGGTGCATCTG -
ACTCCT-3; β-globin minigene reverse primer in exon 2, 5-CCTGAAGTTCTC -
AGGATC-3.
The data presented are the mean values of three independently performed
experiments.
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ATP-binding assay
Binding of ATP to UAP56 or to the UAP56 K95N mutant was assayed by a method
previously used for the DEAD-box helicase eIF4A (Pause and Sonenberg, 1992).
Briefly, 1 μg of purified GST-UAP56 wt or GST-UAP56 K95N mutant were incubated
with 2.5 μCi α-ATP P32 (3000 Ci/mmol) in 30 mM Tris-HCl (pH 7.5), 5 mM
magnesium acetate, 10% glycerol and 1.5 mM DTT for 20 minutes at 37°C. ATP
was cross-linked to the protein by irradiation with a 15 W Westinghouse Steri
Germicidal UV lamp at 4°C, from a distance of 2 cm for 20 minutes. Cross-linking
was done both in the presence and absence of 0.1 A260 units of PolyU (Sigma).
After cross-linking, 4 mM unlabelled ATP was added to the reaction mixture. Finally,
20 μg of RNase A (Qiagen) was added to the reaction and incubated at 37°C for 10
minutes. The samples were then heated to 100°C in SDS PAGE loading buffer for
5 minutes, cooled down to room temperature and loaded on a 12.5% SDS-PAGE gel.
After electrophoresis, the gel was dried, processed for autoradiography and quantified
with a Storm phosphimager.
Statistical analysis
The equivalence of fluorescence curves was evaluated by what has been called the
‘NIH’ method (Feldman, 1988), i.e. fitting third-order polynomial regression curves
to the time series data for each cell and then evaluating differences in means for the
model coefficients between groups. The resulting model coefficients for each subject
were compared overall between groups by multivariate analysis of variance
(MANOVA) (Morrison, 1976). If there had been significant overall differences
between groups by MANOVA, differences between groups for each coefficient (i.e.
linear, quadratic and cubic) would have been evaluated using Student’s t-tests.
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